SCHEMBL13060653

SCHEMBL13060653

Cc1cccc(CN(Cc2ccccc2N2CCOCC2)[C@@H](CC(C)C)CN(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.35
KCNQ2 O43526 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 2/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005626 0.91 RORC (0.35) RORCMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL13061115 0.82 HTR2C (0.40) RORCMEN1KMT2AMAPTLMNA
SCHEMBL13005531 0.81 NCF1 (0.39) RORCMEN1KMT2AMAPTLMNA
SCHEMBL13060690 0.77 CALM1 (0.40) KCNQ2ALDH1A1PIK3CDPIK3CAPIK3CB
SCHEMBL13005588 0.71 CALM1 (0.38) RORCMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL13061127 0.70 ACHE (0.39) MEN1KMT2AL3MBTL1ALDH1A1SLC6A2
SCHEMBL13061104 0.69 KDM4E (0.37) RORCMEN1KMT2ASLC6A2SLC6A4
SCHEMBL13061103 0.69 TSHR (0.35) SLC6A2SLC6A4LMNATSHRCYP1A2
SCHEMBL13061087 0.69 TSHR (0.40) MEN1KMT2AALDH1A1SLC6A2SLC6A4
SCHEMBL13005520 0.68 LMNA (0.37) RORCSLC6A2SLC6A4SLC6A3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed